nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—Myocardial infarction—Etoposide—muscle cancer	0.00356	0.00356	CcSEcCtD
Gadofosveset trisodium—Creatinine increased—Doxorubicin—muscle cancer	0.00354	0.00354	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Vincristine—muscle cancer	0.00353	0.00353	CcSEcCtD
Gadofosveset trisodium—Neck pain—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Gadofosveset trisodium—Sepsis—Methotrexate—muscle cancer	0.00337	0.00337	CcSEcCtD
Gadofosveset trisodium—Abnormal dreams—Doxorubicin—muscle cancer	0.00333	0.00333	CcSEcCtD
Gadofosveset trisodium—Hyperkalaemia—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Gadofosveset trisodium—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00327	0.00327	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Etoposide—muscle cancer	0.00324	0.00324	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Etoposide—muscle cancer	0.00322	0.00322	CcSEcCtD
Gadofosveset trisodium—Oedema—Dactinomycin—muscle cancer	0.0032	0.0032	CcSEcCtD
Gadofosveset trisodium—Fluid retention—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Etoposide—muscle cancer	0.0032	0.0032	CcSEcCtD
Gadofosveset trisodium—Infection—Dactinomycin—muscle cancer	0.00318	0.00318	CcSEcCtD
Gadofosveset trisodium—Blood urea increased—Doxorubicin—muscle cancer	0.00318	0.00318	CcSEcCtD
Gadofosveset trisodium—Vertigo—Vincristine—muscle cancer	0.00315	0.00315	CcSEcCtD
Gadofosveset trisodium—Renal failure acute—Methotrexate—muscle cancer	0.00306	0.00306	CcSEcCtD
Gadofosveset trisodium—Anorexia—Dactinomycin—muscle cancer	0.00305	0.00305	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Etoposide—muscle cancer	0.00305	0.00305	CcSEcCtD
Gadofosveset trisodium—Convulsion—Vincristine—muscle cancer	0.00304	0.00304	CcSEcCtD
Gadofosveset trisodium—Flushing—Etoposide—muscle cancer	0.00303	0.00303	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Etoposide—muscle cancer	0.00303	0.00303	CcSEcCtD
Gadofosveset trisodium—Hypertension—Vincristine—muscle cancer	0.00302	0.00302	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Etoposide—muscle cancer	0.00294	0.00294	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Etoposide—muscle cancer	0.00294	0.00294	CcSEcCtD
Gadofosveset trisodium—Abnormal vision—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Gadofosveset trisodium—Chills—Etoposide—muscle cancer	0.00292	0.00292	CcSEcCtD
Gadofosveset trisodium—Sepsis—Doxorubicin—muscle cancer	0.00292	0.00292	CcSEcCtD
Gadofosveset trisodium—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00292	0.00292	CcSEcCtD
Gadofosveset trisodium—Cerebrovascular accident—Methotrexate—muscle cancer	0.00288	0.00288	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Vincristine—muscle cancer	0.00286	0.00286	CcSEcCtD
Gadofosveset trisodium—Oedema—Vincristine—muscle cancer	0.00286	0.00286	CcSEcCtD
Gadofosveset trisodium—Infection—Vincristine—muscle cancer	0.00284	0.00284	CcSEcCtD
Gadofosveset trisodium—Phlebitis—Doxorubicin—muscle cancer	0.00284	0.00284	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Vincristine—muscle cancer	0.0028	0.0028	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Dactinomycin—muscle cancer	0.00278	0.00278	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Etoposide—muscle cancer	0.00278	0.00278	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Vincristine—muscle cancer	0.00276	0.00276	CcSEcCtD
Gadofosveset trisodium—Fatigue—Dactinomycin—muscle cancer	0.00276	0.00276	CcSEcCtD
Gadofosveset trisodium—Pain—Dactinomycin—muscle cancer	0.00274	0.00274	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Etoposide—muscle cancer	0.00273	0.00273	CcSEcCtD
Gadofosveset trisodium—Anorexia—Vincristine—muscle cancer	0.00273	0.00273	CcSEcCtD
Gadofosveset trisodium—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Gadofosveset trisodium—Irritability—Methotrexate—muscle cancer	0.00269	0.00269	CcSEcCtD
Gadofosveset trisodium—Hypotension—Vincristine—muscle cancer	0.00267	0.00267	CcSEcCtD
Gadofosveset trisodium—Renal failure acute—Doxorubicin—muscle cancer	0.00265	0.00265	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Dactinomycin—muscle cancer	0.00264	0.00264	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00262	0.00262	CcSEcCtD
Gadofosveset trisodium—Renal impairment—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Vincristine—muscle cancer	0.00257	0.00257	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Methotrexate—muscle cancer	0.00255	0.00255	CcSEcCtD
Gadofosveset trisodium—Vertigo—Etoposide—muscle cancer	0.00255	0.00255	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Dactinomycin—muscle cancer	0.00253	0.00253	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Dactinomycin—muscle cancer	0.00253	0.00253	CcSEcCtD
Gadofosveset trisodium—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00253	0.00253	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Etoposide—muscle cancer	0.00249	0.00249	CcSEcCtD
Gadofosveset trisodium—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00249	0.00249	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Vincristine—muscle cancer	0.00249	0.00249	CcSEcCtD
Gadofosveset trisodium—Cough—Etoposide—muscle cancer	0.00248	0.00248	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Vincristine—muscle cancer	0.00247	0.00247	CcSEcCtD
Gadofosveset trisodium—Fatigue—Vincristine—muscle cancer	0.00246	0.00246	CcSEcCtD
Gadofosveset trisodium—Convulsion—Etoposide—muscle cancer	0.00246	0.00246	CcSEcCtD
Gadofosveset trisodium—Hyponatraemia—Doxorubicin—muscle cancer	0.00245	0.00245	CcSEcCtD
Gadofosveset trisodium—Hypertension—Etoposide—muscle cancer	0.00245	0.00245	CcSEcCtD
Gadofosveset trisodium—Pain—Vincristine—muscle cancer	0.00244	0.00244	CcSEcCtD
Gadofosveset trisodium—Constipation—Vincristine—muscle cancer	0.00244	0.00244	CcSEcCtD
Gadofosveset trisodium—Pain in extremity—Doxorubicin—muscle cancer	0.00244	0.00244	CcSEcCtD
Gadofosveset trisodium—Chest pain—Etoposide—muscle cancer	0.00242	0.00242	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0024	0.0024	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Dactinomycin—muscle cancer	0.00236	0.00236	CcSEcCtD
Gadofosveset trisodium—Abdominal discomfort—Methotrexate—muscle cancer	0.00234	0.00234	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Vincristine—muscle cancer	0.00234	0.00234	CcSEcCtD
Gadofosveset trisodium—Confusional state—Etoposide—muscle cancer	0.00234	0.00234	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Etoposide—muscle cancer	0.00232	0.00232	CcSEcCtD
Gadofosveset trisodium—Infection—Etoposide—muscle cancer	0.0023	0.0023	CcSEcCtD
Gadofosveset trisodium—Asthenia—Dactinomycin—muscle cancer	0.0023	0.0023	CcSEcCtD
Gadofosveset trisodium—Blood creatinine increased—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Gadofosveset trisodium—Dehydration—Doxorubicin—muscle cancer	0.00227	0.00227	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Etoposide—muscle cancer	0.00226	0.00226	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Vincristine—muscle cancer	0.00226	0.00226	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Vincristine—muscle cancer	0.00226	0.00226	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Etoposide—muscle cancer	0.00225	0.00225	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Etoposide—muscle cancer	0.00224	0.00224	CcSEcCtD
Gadofosveset trisodium—Hypokalaemia—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Doxorubicin—muscle cancer	0.00221	0.00221	CcSEcCtD
Gadofosveset trisodium—Anorexia—Etoposide—muscle cancer	0.00221	0.00221	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Dactinomycin—muscle cancer	0.00219	0.00219	CcSEcCtD
Gadofosveset trisodium—Nasopharyngitis—Doxorubicin—muscle cancer	0.00219	0.00219	CcSEcCtD
Gadofosveset trisodium—Infestation—Methotrexate—muscle cancer	0.00218	0.00218	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Methotrexate—muscle cancer	0.00218	0.00218	CcSEcCtD
Gadofosveset trisodium—Hypotension—Etoposide—muscle cancer	0.00216	0.00216	CcSEcCtD
Gadofosveset trisodium—Renal failure—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Gadofosveset trisodium—Abdominal distension—Doxorubicin—muscle cancer	0.00213	0.00213	CcSEcCtD
Gadofosveset trisodium—Dysphagia—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Vincristine—muscle cancer	0.00211	0.00211	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Etoposide—muscle cancer	0.00208	0.00208	CcSEcCtD
Gadofosveset trisodium—Haematuria—Methotrexate—muscle cancer	0.00207	0.00207	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Etoposide—muscle cancer	0.00206	0.00206	CcSEcCtD
Gadofosveset trisodium—Asthenia—Vincristine—muscle cancer	0.00205	0.00205	CcSEcCtD
Gadofosveset trisodium—Vomiting—Dactinomycin—muscle cancer	0.00203	0.00203	CcSEcCtD
Gadofosveset trisodium—Bronchitis—Doxorubicin—muscle cancer	0.00203	0.00203	CcSEcCtD
Gadofosveset trisodium—Rash—Dactinomycin—muscle cancer	0.00202	0.00202	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Etoposide—muscle cancer	0.00201	0.00201	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Etoposide—muscle cancer	0.002	0.002	CcSEcCtD
Gadofosveset trisodium—Fatigue—Etoposide—muscle cancer	0.002	0.002	CcSEcCtD
Gadofosveset trisodium—Pain—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Gadofosveset trisodium—Constipation—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Vincristine—muscle cancer	0.00196	0.00196	CcSEcCtD
Gadofosveset trisodium—Pollakiuria—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Etoposide—muscle cancer	0.00191	0.00191	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Gadofosveset trisodium—Nausea—Dactinomycin—muscle cancer	0.0019	0.0019	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Etoposide—muscle cancer	0.00189	0.00189	CcSEcCtD
Gadofosveset trisodium—Dizziness—Vincristine—muscle cancer	0.00189	0.00189	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Doxorubicin—muscle cancer	0.00188	0.00188	CcSEcCtD
Gadofosveset trisodium—Infestation—Doxorubicin—muscle cancer	0.00188	0.00188	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Methotrexate—muscle cancer	0.00188	0.00188	CcSEcCtD
Gadofosveset trisodium—Renal failure—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Gadofosveset trisodium—Urticaria—Etoposide—muscle cancer	0.00184	0.00184	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Etoposide—muscle cancer	0.00183	0.00183	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Etoposide—muscle cancer	0.00183	0.00183	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Methotrexate—muscle cancer	0.00182	0.00182	CcSEcCtD
Gadofosveset trisodium—Vomiting—Vincristine—muscle cancer	0.00182	0.00182	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Methotrexate—muscle cancer	0.00181	0.00181	CcSEcCtD
Gadofosveset trisodium—Rash—Vincristine—muscle cancer	0.0018	0.0018	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Vincristine—muscle cancer	0.0018	0.0018	CcSEcCtD
Gadofosveset trisodium—Haematuria—Doxorubicin—muscle cancer	0.0018	0.0018	CcSEcCtD
Gadofosveset trisodium—Headache—Vincristine—muscle cancer	0.00179	0.00179	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Gadofosveset trisodium—Chills—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Etoposide—muscle cancer	0.00171	0.00171	CcSEcCtD
Gadofosveset trisodium—Erythema—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Gadofosveset trisodium—Nausea—Vincristine—muscle cancer	0.0017	0.0017	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Methotrexate—muscle cancer	0.00166	0.00166	CcSEcCtD
Gadofosveset trisodium—Asthenia—Etoposide—muscle cancer	0.00166	0.00166	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Gadofosveset trisodium—Pruritus—Etoposide—muscle cancer	0.00164	0.00164	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Methotrexate—muscle cancer	0.0016	0.0016	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Etoposide—muscle cancer	0.00158	0.00158	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Gadofosveset trisodium—Flushing—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Gadofosveset trisodium—Dizziness—Etoposide—muscle cancer	0.00153	0.00153	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Gadofosveset trisodium—Vertigo—Methotrexate—muscle cancer	0.00153	0.00153	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Gadofosveset trisodium—Chills—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Gadofosveset trisodium—Cough—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Gadofosveset trisodium—Convulsion—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Gadofosveset trisodium—Vomiting—Etoposide—muscle cancer	0.00147	0.00147	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Gadofosveset trisodium—Erythema—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Gadofosveset trisodium—Rash—Etoposide—muscle cancer	0.00146	0.00146	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Etoposide—muscle cancer	0.00146	0.00146	CcSEcCtD
Gadofosveset trisodium—Headache—Etoposide—muscle cancer	0.00145	0.00145	CcSEcCtD
Gadofosveset trisodium—Flatulence—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Gadofosveset trisodium—Chest pain—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00144	0.00144	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Gadofosveset trisodium—Confusional state—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Methotrexate—muscle cancer	0.00139	0.00139	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Gadofosveset trisodium—Infection—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Gadofosveset trisodium—Nausea—Etoposide—muscle cancer	0.00138	0.00138	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Methotrexate—muscle cancer	0.00135	0.00135	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Methotrexate—muscle cancer	0.00134	0.00134	CcSEcCtD
Gadofosveset trisodium—Vertigo—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Gadofosveset trisodium—Anorexia—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Gadofosveset trisodium—Syncope—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Gadofosveset trisodium—Palpitations—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Gadofosveset trisodium—Hypotension—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Gadofosveset trisodium—Cough—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Gadofosveset trisodium—Convulsion—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Gadofosveset trisodium—Hypertension—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Gadofosveset trisodium—Chest pain—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Gadofosveset trisodium—Anxiety—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Gadofosveset trisodium—Confusional state—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Methotrexate—muscle cancer	0.00121	0.00121	CcSEcCtD
Gadofosveset trisodium—Oedema—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Methotrexate—muscle cancer	0.0012	0.0012	CcSEcCtD
Gadofosveset trisodium—Fatigue—Methotrexate—muscle cancer	0.0012	0.0012	CcSEcCtD
Gadofosveset trisodium—Infection—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Gadofosveset trisodium—Pain—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Gadofosveset trisodium—Shock—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Gadofosveset trisodium—Anorexia—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Methotrexate—muscle cancer	0.00113	0.00113	CcSEcCtD
Gadofosveset trisodium—Hypotension—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Gadofosveset trisodium—Urticaria—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Gadofosveset trisodium—Fatigue—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Gadofosveset trisodium—Pain—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Gadofosveset trisodium—Constipation—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Methotrexate—muscle cancer	0.00102	0.00102	CcSEcCtD
Gadofosveset trisodium—Asthenia—Methotrexate—muscle cancer	0.000995	0.000995	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Doxorubicin—muscle cancer	0.00099	0.00099	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000982	0.000982	CcSEcCtD
Gadofosveset trisodium—Pruritus—Methotrexate—muscle cancer	0.000981	0.000981	CcSEcCtD
Gadofosveset trisodium—Urticaria—Doxorubicin—muscle cancer	0.000954	0.000954	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Doxorubicin—muscle cancer	0.00095	0.00095	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Doxorubicin—muscle cancer	0.00095	0.00095	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Methotrexate—muscle cancer	0.000949	0.000949	CcSEcCtD
Gadofosveset trisodium—Dizziness—Methotrexate—muscle cancer	0.000917	0.000917	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Doxorubicin—muscle cancer	0.000885	0.000885	CcSEcCtD
Gadofosveset trisodium—Vomiting—Methotrexate—muscle cancer	0.000882	0.000882	CcSEcCtD
Gadofosveset trisodium—Rash—Methotrexate—muscle cancer	0.000875	0.000875	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Methotrexate—muscle cancer	0.000874	0.000874	CcSEcCtD
Gadofosveset trisodium—Headache—Methotrexate—muscle cancer	0.000869	0.000869	CcSEcCtD
Gadofosveset trisodium—Asthenia—Doxorubicin—muscle cancer	0.000862	0.000862	CcSEcCtD
Gadofosveset trisodium—Pruritus—Doxorubicin—muscle cancer	0.00085	0.00085	CcSEcCtD
Gadofosveset trisodium—Nausea—Methotrexate—muscle cancer	0.000824	0.000824	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Doxorubicin—muscle cancer	0.000822	0.000822	CcSEcCtD
Gadofosveset trisodium—Dizziness—Doxorubicin—muscle cancer	0.000794	0.000794	CcSEcCtD
Gadofosveset trisodium—Vomiting—Doxorubicin—muscle cancer	0.000764	0.000764	CcSEcCtD
Gadofosveset trisodium—Rash—Doxorubicin—muscle cancer	0.000757	0.000757	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Doxorubicin—muscle cancer	0.000757	0.000757	CcSEcCtD
Gadofosveset trisodium—Headache—Doxorubicin—muscle cancer	0.000753	0.000753	CcSEcCtD
Gadofosveset trisodium—Nausea—Doxorubicin—muscle cancer	0.000714	0.000714	CcSEcCtD
